@FierceMedDev: Tandem Diabetes Care raked in $36M to further market its super-slim insulin pump. News | Follow @FierceMedDev
@MarkHFierce: Covidien expects medical device sales to grow 4% to 7% in FY 2013. Release | Follow @MarkHFierce
@DamianFierce: U.K. engineers have come up with an ultrasound scanner that can made for about $65, targeting developing countries. More | Follow @DamianFierce
> Covidien ($COV) told investors this week that it is on track spinning off its pharmaceuticals business by mid-2013, and that medical device net sales should grow 4% to 7% in fiscal 2013. Release
> Scientists at Seoul National University in South Korea have developed a laser-based needle device that blasts microscopic jets of drugs into the skin, pain free. Release
> Canadian medical device startup Innovative Trauma Care is opening its U.S. headquarters in Texas to drive commercial sales of a clamp that stops bleeding from open wounds within seconds. Story
> The Sorin Group recently gained Chinese FDA approval of its Reply and Esprit families of pacemakers. Release
> Amedica is expanding biomaterial claims for its 510(k)-cleared spinal and reconstructive device implants. Release
> Diagnostics firm Qiagen ($QGEN) is expanding into China, teaming up with Lepu Medical to provide its ESEQuant lateral flow system to test for cardiac biomarkers. More
> The University of California, San Diego's Jacobs School of Engineering has launched a master's program designed to train students for careers in the medical device industry. News
Biotech News
@FierceBiotech: Neural stem cells partially restore mobility in paralyzed rats. Story | Follow @FierceBiotech
@RyanMFierce: My conversation with biotech heavy hitter and NEA partner David Mott about investing big in therapeutics startups. Editor's Corner | Follow @RyanMFierce
> Pharma counts just 3 Alzheimer's drug wins in 13 years (101 losses!). Article
> Massachusetts tops in U.S. for growth in biotech research jobs. Story
> Zambon, Italian pharma partner clash over CNS deal. Report
Pharma News
@FiercePharma: Bayer picks up Teva's animal health biz for $145M. News | Follow @FiercePharma
@EricPFierce: Health Canada says it will rank drug manufacturing issues by risk of product and by 3 levels of concern. FiercePharmaManufacturing article | Follow @EricPFierce
> Mylan may make another acquisition in India. More
> Boehringer Ingelheim lets Facebook game loose. Story